Influenza Virus and SARS-CoV-2 Multiplex Real-Time RT-PCR

Laboratory Fee Schedule
Procedure #:  MCN0312A
 

Synonym(s): COVID-19,flu, influenza surveillance
Requisition FormG-2V
Test DescriptionTesting of samples for the detection and differentiation of SARS-CoV-2, Influenza A virus, and/or Influenza B virus nucleic acid in upper and lower respiratory specimens from individuals with viral respiratory infection symptoms/signs that are consistent with COVID-19.
Pre-Approval NeededN/A
Supplemental Information RequiredN/A
Supplemental Form(s)N/A
Performed on Specimens from (sources)Human
Sample/Specimen Type for Testing

Preferred Specimen:

  • Nasopharyngeal swabs

Alternative Specimens:

  • Oropharyngeal (throat) swabs
  • Nasal swabs
  • Sputum
  • Lower respiratory tract aspirates
  • Bronchoalveolar lavage
  • Nasopharyngeal wash/aspirate
  • Nasal aspirate
Minimum Volume/Size Required2 mL–3 mL
Storage/Preservation Prior to Shipping
  • Store at 2°C–8°C for up to 72 hours.
  • Store frozen, at -70°C or below if storing for longer than 72 hours.
Transport Medium
  • Universal transport media (UTM)
  • Viral transport media (VTM)
Specimen Labeling
  • At least two patient-specific identifiers required on specimen (e.g., patient full name, date of birth, medical record number).
  • Three patient identifiers are preferred.
  • Patient identifiers on specimen label must exactly match identifiers on submission form (e.g., abbreviated name on label and full name on form is not acceptable.)
  • Additional DSHS Laboratory specimen labeling guidelines available online here.
Shipping and Specimen Handling Requirements
  • Refrigerate at 2°C–8°C and ship overnight on frozen gel packs if specimens are expected to arrive at the Lab within 72 hours of collection.
  • Freeze at -70°C and ship overnight on dry ice if specimens are expected to arrive at the Lab more than 72 hours after collection.
  • Ship according to Dangerous Good Regulations, IATA, and/or CFR 49.
  • Handling as infectious agent using universal precautions.
  • Triple-contain in accordance with federal shipping regulations.
  • Submitters are responsible for packaging and shipping specimens according to regulatory requirements.
  • Additional DSHS Laboratory specimen shipping guidelines online here.
MethodReal-Time RT-PCR
Turn-around Time2 business days
Interferences/Limitations
  • False negative may result if specimen is improperly collected, transported, or handled.
  • Detection of viral RNA does not imply that the corresponding virus is infectious or is the causative agent for clinical symptoms.
  • A negative result does not preclude infection.
Common Causes for Rejection
  • Information on the submission form and specimen label do not match.
  • Failure to put at least two unique patient identifiers on specimen label.
  • Incorrect storage conditions.
  • Specimen received at 2°C–8°C more than 72 hours after collection.
  • Specimen received ambient.
  • Specimen leaked in transit.
  • Submission of incorrect specimen type.
  • Expired reagents/media/collection container.
  • Missing/incomplete/illegible submission form.
Additional Information
  • Please mark the Influenza Surveillance {Influenza PCR} and COVID-19 (SARS-CoV-2) PCR boxes on the G-2V submission form.
  • Note: By checking the Influenza Surveillance or COVID-19 PCR test request box, submitters authorize the DSHS Laboratory to test for Flu and/or COVID as resources allow.